100 related articles for article (PubMed ID: 6928507)
1. Anomalous phenotype in thymic acute lymphoblastic leukaemia.
Bradstock KF; Janossy G; Bollum FJ; Milstein C
Nature; 1980 Apr; 284(5755):455-7. PubMed ID: 6928507
[No Abstract] [Full Text] [Related]
2. Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia.
Greaves M; Verbi W; Vogler L; Cooper M; Ellis R; Ganeshaguru K; Hoffbrand V; Janossy G; Bollum FJ
Leuk Res; 1979; 3(6):353-62. PubMed ID: 317656
[No Abstract] [Full Text] [Related]
3. [Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value].
Ifrah N; Perrot JY; Marie JP; Rio B; Julien C; Cadiou M; Boucheix C; Zittoun R
Presse Med; 1985 Jan; 14(3):137-41. PubMed ID: 3156336
[TBL] [Abstract][Full Text] [Related]
4. HLA & surface markers in untreated lymphoid leukaemia patients.
Mehta MM; Contractor NM; Advani SH; Bhatia HM
Indian J Med Res; 1987 Apr; 85():415-9. PubMed ID: 3623651
[No Abstract] [Full Text] [Related]
5. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antigens on acute lymphoblastic leukemias.
Rodt H; Netzel B; Thiel E; Hoffmann-Fezer G; Thierfelder S
Haematol Blood Transfus; 1979; 23():347-52. PubMed ID: 317475
[No Abstract] [Full Text] [Related]
7. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
Campana D; Thompson JS; Amlot P; Brown S; Janossy G
J Immunol; 1987 Jan; 138(2):648-55. PubMed ID: 3098852
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte differentiation and its microenvironment in the human thymus during aging.
Steinmann GG; Müller-Hermelink HK
Monogr Dev Biol; 1984; 17():142-55. PubMed ID: 6431270
[No Abstract] [Full Text] [Related]
9. [Distribution of leukemia-associated antigens (CALLA, P24 antigen and P20 antigen) on childhood acute lymphoblastic leukemia cells and nonhematopoietic tissues].
Ochiai J; Komada Y; Shimizu K; Kamiya H; Sakurai M
Rinsho Ketsueki; 1987 Sep; 28(9):1522-7. PubMed ID: 2963922
[No Abstract] [Full Text] [Related]
10. Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse.
Greaves M; Paxton A; Janossy G; Pain C; Johnson S; Lister TA
Leuk Res; 1980; 4(1):1-14. PubMed ID: 6931949
[No Abstract] [Full Text] [Related]
11. Phenotypic changes in acute lymphoblastic leukemia cells of the common type in diffusion chambers.
Lau B; Jäger G; Thiel E; Pachmann K; Rodt H; Huhn D; Thierfelder S; Dörmer P
Leuk Res; 1980; 4(6):561-9. PubMed ID: 6970862
[No Abstract] [Full Text] [Related]
12. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.
Levy R; Dilley J; Fox RI; Warnke R
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6552-6. PubMed ID: 316541
[TBL] [Abstract][Full Text] [Related]
13. [The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases].
San Miguel JF; Portero JA; Gonzaĺez M; Plaza JP; Caballero MD; De Cecilia A; Fernández JJ; López Borrasca A
Sangre (Barc); 1983; 28(6):746-52. PubMed ID: 6585006
[No Abstract] [Full Text] [Related]
14. HL-A and susceptibility to acute lymphoblastic leukaemia.
Urcan S; Côté GB; Edwards JH
Ann Genet; 1974 Jun; 17(2):73-6. PubMed ID: 4547943
[No Abstract] [Full Text] [Related]
15. Studies on normal B-cells and common acute lymphoblastic leukemia blast cells using a colony assay.
Izaguirre CA; Greaves MF
Haematol Blood Transfus; 1983; 28():366-8. PubMed ID: 6602743
[No Abstract] [Full Text] [Related]
16. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
[No Abstract] [Full Text] [Related]
17. Clinical usefulness of monoclonal-antibody phenotyping in childhood acute lymphoblastic leukemia.
Kersey J; Goldman A; Abramson C; Nesbit M; Perry G; Gajl-Peczalska K; LeBien T
Lancet; 1982 Dec; 2(8313):1419-23. PubMed ID: 6129506
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level.
van Dongen JJ; Quertermous T; Bartram CR; Gold DP; Wolvers-Tettero IL; Comans-Bitter WM; Hooijkaas H; Adriaansen HJ; de Klein A; Raghavachar A
J Immunol; 1987 Feb; 138(4):1260-9. PubMed ID: 3100631
[TBL] [Abstract][Full Text] [Related]
19. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic characterization and classification of T-acute lymphoblastic leukemia. Report of 30 cases.
Ferrara F; Cimino R; De Rosa C; Lo Pardo C; Montuori R; Pace E; Vacca C; Del Vecchio L
Haematologica; 1987; 72(3):227-31. PubMed ID: 3114088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
